athenahealth, Inc. (NASDAQ:ATHN) had its price objective lowered by analysts at Jefferies Group LLC from $135.00 to $120.00 in a report issued on Friday. The brokerage presently has a “hold” rating on the health services provider’s stock. Jefferies Group LLC’s price objective points to a potential downside of 6.93% from the company’s current price.

Several other equities research analysts have also issued reports on ATHN. Evercore ISI reaffirmed an “outperform” rating and set a $147.00 target price (up from $118.00) on shares of athenahealth in a research report on Friday, May 19th. Leerink Swann set a $140.00 target price on athenahealth and gave the company a “hold” rating in a research report on Friday, May 19th. Robert W. Baird set a $140.00 target price on athenahealth and gave the company a “buy” rating in a research report on Thursday, May 18th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $140.00 target price (up from $118.00) on shares of athenahealth in a research report on Friday, May 19th. Finally, Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and set a $154.00 target price (up from $119.00) on shares of athenahealth in a research report on Monday, May 22nd. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and thirteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $148.41.

athenahealth (ATHN) traded down 1.49% during trading on Friday, reaching $128.94. 399,272 shares of the company’s stock were exchanged. The firm’s 50-day moving average price is $139.35 and its 200-day moving average price is $128.79. athenahealth has a 12 month low of $90.11 and a 12 month high of $158.66. The firm has a market cap of $5.15 billion, a price-to-earnings ratio of 163.63 and a beta of 1.79.

athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.12. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The firm had revenue of $301.10 million during the quarter, compared to analyst estimates of $298.68 million. During the same period last year, the firm posted $0.34 EPS. The business’s revenue was up 15.0% compared to the same quarter last year. On average, equities research analysts anticipate that athenahealth will post $1.91 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark legislation. The correct version of this news story can be read at https://www.americanbankingnews.com/2017/09/15/athenahealth-inc-athn-rating-reiterated-by-jefferies-group-llc.html.

In other news, SVP Jonathan D. Porter sold 300 shares of athenahealth stock in a transaction dated Monday, July 17th. The stock was sold at an average price of $143.13, for a total transaction of $42,939.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Brandon H. Hull sold 800 shares of athenahealth stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $140.81, for a total value of $112,648.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,422 shares of company stock valued at $2,182,607. Corporate insiders own 3.20% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. Turner Investments LLC bought a new stake in shares of athenahealth during the 2nd quarter valued at about $105,000. Bessemer Group Inc. boosted its position in shares of athenahealth by 13.7% during the 2nd quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock valued at $132,000 after acquiring an additional 113 shares during the last quarter. FNY Partners Fund LP boosted its position in shares of athenahealth by 1,900.0% during the 1st quarter. FNY Partners Fund LP now owns 1,000 shares of the health services provider’s stock valued at $112,000 after acquiring an additional 950 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of athenahealth by 7.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after acquiring an additional 84 shares during the last quarter. Finally, Seven Bridges Advisors LLC boosted its position in shares of athenahealth by 5.4% during the 2nd quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock valued at $183,000 after acquiring an additional 67 shares during the last quarter.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.